Skip to content
10-Q

Quarterly Report

QUANTRX BIOMEDICAL CORPORATION

0001851734-21-000104

← back to feed
Filed
Nov 16, 2021 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Nov 15, 2021 78.7M sh
Cash And Equivalents Q3 2021 · Sep 30, 2021 $21.05K
Cash And Equivalents Q3 2021 · Dec 31, 2020 $55.43K
Total Liabilities Q3 2021 · Sep 30, 2021 $2.6M
Total Liabilities Q3 2021 · Dec 31, 2020 $2.44M
Current Assets Q3 2021 · Sep 30, 2021 $21.05K
Current Assets Q3 2021 · Dec 31, 2020 $55.43K
Total Assets Q3 2021 · Sep 30, 2021 $21.05K
Total Assets Q3 2021 · Dec 31, 2020 $55.43K
Operating Cash Flow Q3 2021 · Sep 30, 2020 −$69.09K
Stockholders Equity Q3 2021 · Sep 30, 2020 −$2.32M
Stockholders Equity restated Q3 2021 · Jun 30, 2020 −$2.17M
Stockholders Equity Q3 2021 · Dec 31, 2019 −$2.13M
Sga Expense Q3 2021 · Sep 30, 2020 $1.91K
Sga Expense Q3 2021 · Sep 30, 2020 $8.8K
Net Income Q3 2021 · Sep 30, 2020 −$65.17K
Net Income Q3 2021 · Sep 30, 2020 −$189.17K
Operating Income Q3 2021 · Sep 30, 2020 −$10.69K
Operating Income Q3 2021 · Sep 30, 2020 −$51.53K